Active Pharma Ingredients (APIs)

JPN Pharma is a global leader in the production of large-volume generic Active Pharmaceutical Ingredients (APIs), committed to upholding environmental safety and sustainability at every stage. Our facilities boast prestigious EDQM (European Directorate for the Quality of Medicines) and WHO-GMP (World Health Organization - Good Manufacturing Practices) approvals, underscoring our expertise in handling hazardous chemicals and executing complex reactions with meticulous precision. Supported by a dedicated R&D setup and stringent QA/QC practices, we ensure uncompromising quality across varied batch sizes and reactor volumes ranging from 5 to 8000 liters.

At JPN Pharma, sustainability is ingrained in our operational ethos. We employ environmentally responsible production methods and prioritize the use of clean fuel in our boiler operations. Our advanced equipment includes the Agitated Nutsche Filter Dryer (ANFD) and Rotary Vacuum Paddle Dryer, enabling safe and efficient production, particularly for temperature-sensitive products. Managed by JPN LLP, our Zero Liquid Discharge facility exemplifies our commitment to minimizing environmental impact.

Trusted by esteemed pharmaceutical leaders like Cipla, Glenmark, Zydus, and Abbott, JPN Pharma specializes in manufacturing APIs on a significant scale. Situated in Maharashtra, our GMP and FDA-approved facilities are dedicated to producing essential molecules that play a pivotal role in global healthcare solutions.

Our APIs are used across various therapeutic categories, including:

Topical antimicrobials

Cardiovascular treatments

Hypertension and heart failure management

Bone health

Benign prostatic hyperplasia

Anticonvulsants

Dementia care

JPN Pharma continues to lead the industry with a steadfast commitment to
quality, sustainability and innovation.

Phenobarbital USP
PRODUCT SPECIFICATIONS

Name of Product :- PHENOBARBITAL USP

A.R. No. FP/049/24

 DMF  

SR. NO

CRITERIA

SPECIFICATION

1

Description

White, odorless, glistening, small crystals, or white, crystalline powder, which may exhibit polymorphism. Is stable in air. Its saturated solution has a pH of about 5.

2

Solubility

Soluble in alcohol, in ether and in solutions of fixed alkali hydroxides and carbonate; sparingly soluble in chloroform; very slightly soluble in water.

3

Identification

A) By IR

A) The infrared spectrum of the sample should concordant with the infrared spectrum of the Phenobarbital working/ reference standard obtained in same manner.

B) By HPLC

B) The retention time of the major peak of the Chromatogram of the assay preparation corresponds to that of the standard preparation, both relative to the internal Standard as obtained in the assay.

4

Melting Range

Between 174°C and 178°C

5

Loss on drying

Not more than 1.0%

6

Residue on ignition


Not more than 0.15%

7

Assay (By HPLC)

Not more than 0.5% w/w

*Additional Test:

8

Residual Solvent GCHS

Methanol

Benzene

Toluene


Not more than 3000ppm

Not more than 2ppm

Not more than 890ppm

The material complies as per USP 46 Specification.
Close

Close
Navigation
Categories